nib Presentation_FINAL.pdf



2 October 2015 The Manager

Company Announcements

Australia Securities Exchange Limited Level 4, Bridge Street

SYDNEY NSW 2000


Presentation to J.P. Morgan Access Days - October 2015

nib holdings limited Head Office

22 Honeysuckle Drive

Newcastle NSW 2300

abn 51 125 633 856

t 13 14 63

f 02 4925 1999


e nib@nib.com.au

w nib.com.au


Attached presentation to be delivered by nib at the J.P. Morgan Access Days from 5 October 2015. All information contained within this presentation has been previously disclosed to the ASX.


Yours sincerely


Michelle McPherson

Company Secretary/Chief Financial Officer


J.P. MORGAN


ACCESS DAYS 2015


HIUT'S


MGOODATO BNE



October 2015 | All figures in this document are represented in Australian dollars unless otherwise stated

2


Agenda


Healthcare in Australia

About nib Our performance


Business Strategy

Appendix

Key performance metrics and outlook

3


Healthcare in Australia

Growth in healthcare spending driven by; wealth effect, ageing, rise of chronic disease, cost of new technology, supply induced demand and moral hazard.


$147.4b


2013 | Australian healthcare spending ($b)


Australian treasury projection

  1. Health Aged care Age/service pensions

    Education Defense

    5.0

    Components of healthcare spending

    40% 18% 14% 7% 5% 16%


    GDP (%)

    4.0


    3.0


    2.0


    1.0

    Hospitals Medical services

    Medicines Dental Services

    Community health

    Other


    0.0


    2014/15


    2024/25


    2034/35


    2044/45


    2054/55


    Source: AIHW 2013 Health Expenditure Australia

    Source: Treasury Projections (2015 Intergenerational Report)


    4


    The role of Private Health Insurance (PHI)


    Australian PHI growth drivers:

    Increasing wealth and favourable economic circumstances

    Dissatisfaction with public system and rationing

    Competition and investment in marketing and growth

    Government 'sticks and carrots'

    What PHI does and doesn't cover


    Public & Private Hospital

    Medical specialist

    Medical specialist

    Pharmaceuticals In hospital

    Pharmaceuticals outside hospital

    Diagnostics (x-ray, blood

    Diagnostics (x-ray, blood

    (accommodation,

    (surgeon,

    (surgeon,

    tests) in

    tests) outside

    (dental, optical,

    theatre, etc), choice

    anaesthetist )

    anaesthetist )

    hospital

    hospital

    etc)

    of specialist

    in hospital

    outside hospital

    General Treatment cover

    Ambulance

    5


    PHI structure in Australia

    At 30 June 2014 there were 34 private health insurers operating in Australia. Top five PHI players represent 83% of the polices nationally.

    For profit insurers make up around 68% of the industry. Direct to Consumer (DTC) accounts for ~85% sales.

    Policies are community rated (i.e. not risk rated).

    Approximately 56% of population have private health insurance.


    Private Health Insurance


    8%

    Medibank BUPA HCF HBF

    nib

    Other


    * Source: Private Health Insurance Administration Council - The Operations of Private Health Insurers Annual Report 2013-14

    6


    About nib (ASX: NHF)


    FY15 Group premium revenue of

    $1.63b, operating profit of $81.7m, net profit after tax of $75.3m

    More than 1,000 employees in Australia and New Zealand

    Australia's 4th largest private health insurer, New Zealand's 2nd largest private health insurer

    Market capitalisation ~$1.4b (439m shares on issue,

    75% retail: 25% institution)

    Approximately 1.3 million customers throughout Australia and New Zealand

    PHI markets Australian residents New Zealand residents International workers International students

    Other markets* Travel Insurance Life Insurance

    nib Options - domestic and international cosmetic treatment (launched in

    March 2014)

    Recent M&A

    TOWER Medical Insurance Limited acquired November 2012 for approximately $73m (purchase price was $81.3m, which included $7.9m in surplus capital, which equates to approximately $73m)

    World Nomads Group acquired July 2015 for total consideration of $95m (Australia's third largest distributor of travel insurance)


    * Non-underwriting

    7


    Business Strategy


    Achieve above 'system' growth in the Australian Insurance Resident Health (arhi) market.

    Grow our International Workers (iwhi) and International Students (ishi) market share.

    Position and build our business in New Zealand as a 'challenger' and grow the market and our share.

    Leverage core business capabilities to pursue adjacent business opportunities.


    Design product benefits and manage claims in accordance with our strategic and commercial objectives.

    Develop 'Whitecoat' and our digital platform to create an unrivalled customer experience and support health and clinical decision making by customers.

    Increase customer satisfaction, productivity and efficiency.

    Have the 'right people on the bus', develop a high performance organisational culture and advance the engagement of our people.

    8


    FY15 nib

    Group performance metrics


    Premium Revenue Operating Profit

    Earnings per share


    1.6b 81.7m 17.3c


    Net profit after tax

    75.3m

    Return on Equity Dividends per share


    23.1%


    9


    arhi key performance metrics and outlook


    FY15


    Surpassed 1 million customers covered. Annual net policyholder growth of

    4.7% versus 2.5% for the industry, with nib accounting for almost 15% of industry growth.


    Net margin of 5.0%, within 5.0% to 5.5% target range

    Above system policyholder growth for nib with focus upon under 40s and over 55s. nib has achieved above industry annual policyholder growth for over a decade.

    We expect the market to continue to grow and to increase our market share and earnings.

    System growth will continue for a number of reasons, including inevitable funding shift from Government to private sector.

    Premium revenue up 8.8% to

    $1.4 billion

    Net growth remains highly value accretive. nib's target net margin range is 5%-5.5%.

    Lapse rate clearly indicates growth is not without headwinds. Downgrading while present, is not impacting top line growth and profitability.

    M&A prospects remain limited but logic of industry consolidation remains compelling. Impending Government review of PHI.


    10


    International and new business

    FY15


    International (Inbound) Health Insurance business Operating profit up 4.0% to

    $11.8 million


    Insuring almost 88,000 international students and overseas visitors (up 54.2%)


    Acquisition of travel insurance provider World Nomads Group

    'Complementary' business will continue to make a major contribution to pre-tax operating earnings and further opportunities are very real.

    International (Inbound) Health Insurance business (students and workers) policyholder growth but profitability may be weaker. Need for more assertive care co-ordination evident.

    World Nomads Group (WNG) underlying1 FY16 operating profit of at least $10m.


  2. Excluding one-off transaction costs and amortisation of acquisition related identifiable intangibles.


11


nib New Zealand key performance metrics and outlook

FY15


Direct-to-consumer account for approximately 50% of all sales


Policyholder growth of 5.9%


Premium revenue up 8.1% to

$150.4 million


nib New Zealand profitability to improve in FY16 due to improved scale and growth. Further investment in DTC, a focus on advisor channel, a renewed effort on group/employer market, third party distribution and M&A.

distributed by